China National Center For Cardiovascular Diseases
Clinical trials sponsored by China National Center For Cardiovascular Diseases, explained in plain language.
-
Ancient herb berberine tested to stop heart disease and diabetes in its tracks
Prevention OngoingThis large, phase 4 trial is testing whether berberine, a natural compound, can prevent heart disease and diabetes in over 2,000 adults in China who are at high risk. Participants take berberine or a placebo twice a day, along with lifestyle advice. The study looks at blood sugar…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Prevention
Last updated Jun 23, 2026 11:57 UTC
-
Heart study seeks clues in rare muscle conditions
Knowledge-focused OngoingThis study looks at 165 people with two types of heart muscle thickening: syndromic/metabolic cardiomyopathy (SMC) and hypertrophic cardiomyopathy (HCM). Researchers want to see if SMC patients have worse heart outcomes like death or stroke. They also aim to find what risk factor…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:04 UTC
-
LVAD Patients' infection risks under the microscope
Knowledge-focused OngoingThis study looks at 120 adults getting a left ventricular assist device (LVAD) to see how often infections happen and how their immune system changes after surgery. The goal is to find what makes some patients more likely to get infections. This research does not test a new treat…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:04 UTC